Summit Financial Strategies, Inc. Merck & Co., Inc. Transaction History

Summit Financial Strategies, Inc.

$749 Million
Q2 2024

A detailed history of Summit Financial Strategies, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Summit Financial Strategies, Inc. holds 5,400 shares of MRK stock, worth $592,758. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,400

Previous 5,626 4.02%

Holding current value

$592,758

Previous $742,000 9.97%

% of portfolio

0.09%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $27,978 - $30,048	-226 Reduced 4.02%	5,400 $668,000
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $18,911 - $22,035	-167 Reduced 2.88%	5,626 $742,000
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $38,194 - $42,416	-371 Reduced 6.02%	5,793 $596,000
Q2 2023 Jul 21, 2023	BUY	$108.61 - $118.38 $14,336 - $15,626	132 Added 2.19%	6,164 $711,000
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $99,748 - $111,299	-969 Reduced 13.84%	6,032 $641,000
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $264,943 - $339,693	-3,030 Reduced 30.21%	7,001 $0
Q3 2022 Oct 21, 2022	BUY	$84.53 - $94.96 $253,674 - $284,974	3,001 Added 42.69%	10,031 $864,000
Q2 2022 Jul 25, 2022	BUY	$83.49 - $94.64 $70,966 - $80,444	850 Added 13.75%	7,030 $641,000
Q1 2022 May 04, 2022	BUY	$73.51 - $82.4 $441 - $494	6 Added 0.1%	6,180 $507,000
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $17,704 - $19,471	247 Added 4.17%	6,174 $464,000
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $16,733 - $18,509	238 Added 4.18%	5,927 $461,000
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $8,676 - $10,219	-126 Reduced 2.17%	5,689 $439,000
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $30,574 - $33,930	426 Added 7.9%	5,815 $476,000
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $52,689 - $59,724	-720 Reduced 11.79%	5,389 $447,000
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $17,957 - $20,433	255 Added 4.36%	6,109 $472,000
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $62,029 - $85,975	-979 Reduced 14.33%	5,854 $450,000
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $28,239 - $31,864	364 Added 5.63%	6,833 $621,000
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $76 - $82	1 Added 0.02%	6,469 $545,000
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $2,304 - $2,692	-33 Reduced 0.51%	6,468 $542,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $6,958 - $7,936	-100 Reduced 1.51%	6,501 $541,000
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $6,067 - $7,041	93 Added 1.43%	6,601 $504,000
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $5,422 - $6,376	-94 Reduced 1.42%	6,508 $462,000
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $10,216 - $12,003	201 Added 3.14%	6,602 $401,000
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $7,083 - $8,232	139 Added 2.22%	6,401 $349,000
Q4 2017 Jan 29, 2018	SELL	$51.62 - $61.64 $53,942 - $64,413	-1,045 Reduced 14.3%	6,262 $352,000
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $428,701 - $461,290	7,307	7,307 $468,000

Others Institutions Holding MRK

# of Institutions

3,826

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Strategies, Inc. with notifications on news.

Account

Summit Financial Strategies, Inc. Merck & Co., Inc. Transaction History